知镜 Cognispect · 医学文献与研究工作台

CD163+ macrophage infiltration reflects disease activity and early treatment response in lupus nephritis.

Crum SD, Kwant L, Sela G, Claessen N, Roelofs JJTH, De Boer O, Kwakernaak AJ, Vogt L, Florquin S, Tsang-A-Sjoe MWP, Van Der Putten TJ, Vegting Y, Hilhorst M.
Clinical and experimental rheumatology · 2026-11-05 · PMID 43001865

文献摘要

Objectives Lupus nephritis (LN) is a severe manifestation of systemic lupus erythematosus, potentially leading to progressive kidney damage and end-stage kidney disease. Emerging evidence suggests that macrophages play a key role in LN pathogenesis. The aim of this study was to investigate associations between renal macrophage infiltration and clinical, histopathological, and long-term renal outcomes in LN. Methods This retrospective cohort study included 58 biopsy-proven LN patients (2002-2018), with a mean follow-up of 77 months. Immunohistochemistry for CD68, CD163, CD206, and C5aR1 macrophage markers was performed on baseline kidney biopsies. Correlations with histological features and clinical parameters such as kidney function (eGFR), proteinuria and long-term renal outcomes were analysed using correlation matrices and linear mixed models. Results CD163+ macrophage infiltration in glomerular and tubulointerstitial compartments was significantly associated with clinical and histological activity, including lower baseline eGFR, lower complement levels, more leukocyturia/erythrocyturia and higher activity index scores. Patients with high CD163+ infiltration demonstrated significantly greater improvement of eGFR and proteinuria during the first 6 months of treatment post-diagnosis. Conversely, low CD163+ infiltration was associated with increased likelihood of requiring a repeat biopsy. These associations were not observed when stratifying by LN class. CD68+ macrophages showed a similar trend. CD206+ and C5aR1+ macrophages were not associated with markers of disease activity, although high glomerular C5aR1+ infiltration was linked to repeat biopsy. None of the macrophage markers were associated with long-term outcomes such as renal flares, dialysis, or transplantation. Conclusions CD163+ macrophage infiltration at baseline is associated with active disease and early treatment response in LN, independent of received treatment. While LN class guides treatment choice, CD163+ macrophage infiltration may offer additional prognostic value regarding early therapeutic response. These findings support further investigation of CD163+ macrophages as a biomarker not only providing prognostic information but also helping guide treatment choices beyond the current LN classification system.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。